Molecular basis for isoform-selective inhibition of presenilin-1 by MRK-560

Nat Commun. 2022 Oct 22;13(1):6299. doi: 10.1038/s41467-022-33817-5.

Abstract

Inhibition of γ-secretase activity represents a potential therapeutic strategy for Alzheimer's disease (AD). MRK-560 is a selective inhibitor with higher potency for Presenilin 1 (PS1) than for PS2, the two isoforms of the catalytic subunit of γ-secretase, although the underlying mechanism remains elusive. Here we report the cryo-electron microscopy (cryo-EM) structures of PS1 and PS2-containing γ-secretase complexes with and without MRK-560 at overall resolutions of 2.9-3.4 Å. MRK-560 occupies the substrate binding site of PS1, but is invisible in PS2. Structural comparison identifies Thr281 and Leu282 in PS1 to be the determinant for isoform-dependent sensitivity to MRK-560, which is confirmed by swapping experiment between PS1 and PS2. By revealing the mechanism for isoform-selective inhibition of presenilin, our work may facilitate future drug discovery targeting γ-secretase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid Precursor Protein Secretases* / metabolism
  • Cryoelectron Microscopy
  • Presenilin-1 / genetics
  • Presenilin-1 / metabolism
  • Presenilin-2
  • Protein Isoforms

Substances

  • Presenilin-1
  • Amyloid Precursor Protein Secretases
  • Presenilin-2
  • MRK 560
  • Protein Isoforms